Narayana Hrudayalaya Limited (NSE: NH)
India
· Delayed Price · Currency is INR | Market Cap | 258.38B |
| Revenue (ttm) | 52.21B |
| Net Income (ttm) | 7.79B |
| Shares Out | 203.10M |
| EPS (ttm) | 38.35 |
| PE Ratio | 33.17 |
| Forward PE | 31.09 |
| Dividend | 4.00 (0.31%) |
| Ex-Dividend Date | Aug 2, 2024 |
| Volume | 168,063 |
| Open | 1,256.00 |
| Previous Close | 1,258.95 |
| Day's Range | 1,256.00 - 1,289.50 |
| 52-Week Range | 1,080.00 - 1,444.90 |
| Beta | 0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 7, 2024 |
About Narayana Hrudayalaya
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology se... [Read more]
Financial Performance
In 2023, Narayana Hrudayalaya's revenue was 50.18 billion, an increase of 10.79% compared to the previous year's 45.30 billion. Earnings were 7.89 billion, an increase of 30.19%.
Financial StatementsNews
Stocks in focus: Tata Invest, Narayana Hrudayalaya, BF Utilities, Sudarshan Pharma and others set to announce Q2 FY24-25 results today
A series of key financial results for the quarter ending September 2024 are expected today from several companies. Notable among them are Tata Investment Corporation and Narayana Hrudayalaya, whose fi...